STERLINBIO

Sterling Biotech Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 31, 2011 has recommended 50% (Rs. 0.50 per equity share of F.V. of Re.1/- each) dividend on the equity shares for the financial year ended December 31, 2010 subject to approval of the members at the ensuing Annual General Meeting.

Sterling Biotech Limited has informed the Exchange that the Board of Directors at their meeting held on March 31, 2010 has recommended 50% (Rs. 0.50 per equity share of F.V of Re. 1/- each) dividend on the equity shares for the financial year ended December 31, 2009 subject to approval of the members at the ensuing Annual General Meeting.

Sterling Biotech Limited has informed the Exchange that the Board of Director at its meeting held on March 31, 2009, the Board has recommended 50% (Rs 0.50 per equity share of F.V. of Re. 1 /- each) dividend on the equity shares for the financial year ended December 31, 2008 subject to approval of the members.

Sterling Biotech Limited has informed the Exchange that the Board, at its meeting held on March 31, 2008 has recommended 50% (Rs.0.50 per equity share of FV of Rs.1/-) dividend on the equity shares for the financial year ended December 31, 2007 subject to approval of the members.

Sterling Biotech Limited has informed the Exchange that the Board has recommended 50% (Rs.0.50 per equity shares of FV of Rs.1/-) dividend on the equity shares for the financial year ended 31st December 2006 subject to approval of the members at the ensuing Annual General Meeting of the Company. The Board has also approved on enabling resolution for issue of equity or equity related instruments or any other convertible instrument aggregating up to US$ 300 million, if required in future, as detailed in the resolution. The enabling resolution will be subject to all necessary permissions and app

Sterling Biotech Limited has informed the Exchange that the board in its meeting held on March 28, 2006 has recommended dividend @ 50% on the equity share capital (i.e Rs. 0.50 per equity share of face value of Rs.1.00) of the company for the year ended December 31,2005. The Payment of Dividend is subject to the approval of the Members at the Annual General Meeting of the Company.

Sterling Biotech Limited has informed the Exchange that the Board at its meeting held on April 30, 2005, have recommended a dividend @ 30% on equity shares i.e. Rs.0.30 on equity shares of Re.1/- each, for the FY ended on December 31, 2004 subject to the approval of the Members at the AGM of the Company.